Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026

Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development and delivery of Self-Driving Laboratories (SDL), with an adjusted EBITA loss of $0.7 million consistent with management's expectations.